Alpelisib(PIQRAY)
Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection
Reference price:
Manufacturer:
Novartis
Formulation:
TABLET
Validity period:
24 months
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Alpelisib(PIQRAY) Instructions:Uses,Dosage, Side Effects

PIQRAY, with the generic name alpelisib, is a kinase inhibitor that specifically targets the phosphatidylinositol-3-kinase alpha (PI3Kα) protein. Its active pharmaceutical ingredient is alpelisib, formulated as film-coated tablets for oral administration. It is designed for use in combination with fulvestrant to target cancers harboring specific genetic mutations.

Generic name

Alpelisib(PIQRAY)
English name
Alpelisib
Alternative Names
PIQRAY
Drug prices
Indications

PIQRAY, in combination with fulvestrant, is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer, as detected by an FDA-approved test, following disease progression on or after endocrine-based regimen.

Therapeutic Target
PI3Kα
Active Ingredients
Alpelisib
Dosage form
TABLET
specifications
150mg * 28 tablets/box
Description
Dosage and Administration

300 mg (two 150 mg tablets) taken orally once daily with food.

RECOMMENDED ARTICLES
RELATED ARTICLES
How to Use Alpelisib (Piqray)

Alpelisib (Piqray) is a kinase inhibitor, first approved in the United States in 2019. Used in combination with...

Friday, December 5th, 2025, 09:39
What Kind of Drug Is Alpelisib (Piqray)?

Alpelisib (Piqray) is a kinase inhibitor, first approved in the United States in 2019. As a targeted therapy for...

Friday, December 5th, 2025, 09:35
How to Purchase Alpelisib (Piqray)

Alpelisib (Piqray) is a phosphatidylinositol-3-kinase (PI3K) inhibitor. It is indicated for adult patients with...

Friday, December 5th, 2025, 09:32
Precautions for the Administration of Alpelisib (Piqray)

Alpelisib (Piqray) is a phosphatidylinositol-3-kinase (PI3K) inhibitor administered orally, and strict adherence to...

Thursday, September 4th, 2025, 16:37
What are the precautions for Alpelisib (PIQRAY)?

Alpelisib (PIQRAY) is a targeted therapy for patients with breast-related diseases with specific gene...

Monday, July 7th, 2025, 11:31
Are the side effects of Alpelisib serious?

Alpelisib is an inhibitor that targets the PI3K pathway, specifically the PI3Kα isoform. Mutations in the...

Monday, July 7th, 2025, 11:28
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved